CBIO
Crescent Biopharma, Inc. Common Stock
CBIO
CBIO
81 hedge funds and large institutions have $535M invested in Crescent Biopharma, Inc. Common Stock in 2017 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 25 increasing their positions, 20 reducing their positions, and 10 closing their positions.
Holders
81
Holders Change
+22
Holders Change %
+37.29%
% of All Funds
1.84%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
32
Increased
25
Reduced
20
Closed
10
Calls
$2.14M
Puts
$3.96M
Net Calls
-$1.81M
Net Calls Change
-$1.62M
Top Buyers
| 1 |
1
Fidelity Investments
Boston,
Massachusetts
|
$47.7M |
| 2 |
RG
2
Redmile Group
San Francisco,
California
|
$32.4M |
| 3 |
PC
3
Polar Capital
London,
United Kingdom
|
$11.4M |
| 4 |
4
Axa
Paris,
France
|
$8.58M |
| 5 |
5
Janus Henderson Group
London,
United Kingdom
|
$16.4M |
